Connection

ADEL K EL-NAGGAR to Carcinoma, Adenoid Cystic

This is a "connection" page, showing publications ADEL K EL-NAGGAR has written about Carcinoma, Adenoid Cystic.
Connection Strength

9.817
  1. Intratumoral microbiome of adenoid cystic carcinomas and comparison with other head and neck cancers. Sci Rep. 2024 07 15; 14(1):16300.
    View in: PubMed
    Score: 0.685
  2. Phase II Clinical Trial of Axitinib and Avelumab in Patients With Recurrent/Metastatic Adenoid Cystic Carcinoma. J Clin Oncol. 2023 05 20; 41(15):2843-2851.
    View in: PubMed
    Score: 0.624
  3. Whole-Genome Sequencing of Common Salivary Gland Carcinomas: Subtype-Restricted and Shared Genetic Alterations. Clin Cancer Res. 2021 07 15; 27(14):3960-3969.
    View in: PubMed
    Score: 0.550
  4. Proteogenomic Analysis of Salivary Adenoid Cystic Carcinomas Defines Molecular Subtypes and Identifies Therapeutic Targets. Clin Cancer Res. 2021 02 01; 27(3):852-864.
    View in: PubMed
    Score: 0.531
  5. Spatio-Temporal Genomic Heterogeneity, Phylogeny, and Metastatic Evolution in Salivary Adenoid Cystic Carcinoma. J Natl Cancer Inst. 2017 10 01; 109(10).
    View in: PubMed
    Score: 0.428
  6. Novel MYBL1 Gene Rearrangements with Recurrent MYBL1-NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations. Clin Cancer Res. 2016 Feb 01; 22(3):725-33.
    View in: PubMed
    Score: 0.377
  7. Analysis and significance of c-MET expression in adenoid cystic carcinoma of the salivary gland. Cancer Biol Ther. 2015; 16(6):834-8.
    View in: PubMed
    Score: 0.362
  8. Development and characterization of salivary adenoid cystic carcinoma cell line. Oral Oncol. 2014 Oct; 50(10):991-9.
    View in: PubMed
    Score: 0.343
  9. Expression and significance of notch signaling pathway in salivary adenoid cystic carcinoma. Ann Diagn Pathol. 2014 Feb; 18(1):10-3.
    View in: PubMed
    Score: 0.325
  10. MicroRNA profiling of salivary adenoid cystic carcinoma: association of miR-17-92 upregulation with poor outcome. PLoS One. 2013; 8(6):e66778.
    View in: PubMed
    Score: 0.318
  11. Novel chromosomal rearrangements and break points at the t(6;9) in salivary adenoid cystic carcinoma: association with MYB-NFIB chimeric fusion, MYB expression, and clinical outcome. Clin Cancer Res. 2011 Nov 15; 17(22):7003-14.
    View in: PubMed
    Score: 0.283
  12. Clinical significance of Myb protein and downstream target genes in salivary adenoid cystic carcinoma. Cancer Biol Ther. 2011 Oct 01; 12(7):569-73.
    View in: PubMed
    Score: 0.282
  13. Developmental transcription factor EN1--a novel biomarker in human salivary gland adenoid cystic carcinoma. Cancer. 2012 Mar 01; 118(5):1288-92.
    View in: PubMed
    Score: 0.279
  14. CpG island methylation profiling in human salivary gland adenoid cystic carcinoma. Cancer. 2011 Jul 01; 117(13):2898-909.
    View in: PubMed
    Score: 0.269
  15. Cell type-dependent biomarker expression in adenoid cystic carcinoma: biologic and therapeutic implications. Cancer. 2010 Dec 15; 116(24):5749-56.
    View in: PubMed
    Score: 0.262
  16. Comprehensive analysis of the MYB-NFIB gene fusion in salivary adenoid cystic carcinoma: Incidence, variability, and clinicopathologic significance. Clin Cancer Res. 2010 Oct 01; 16(19):4722-31.
    View in: PubMed
    Score: 0.261
  17. Deletion of 1p32-p36 is the most frequent genetic change and poor prognostic marker in adenoid cystic carcinoma of the salivary glands. Clin Cancer Res. 2008 Aug 15; 14(16):5181-7.
    View in: PubMed
    Score: 0.227
  18. Translocation t(6;14) as the sole chromosomal abnormality in adenoid cystic carcinoma of the base of tongue. Head Neck Pathol. 2007 Dec; 1(2):165-8.
    View in: PubMed
    Score: 0.215
  19. First Use of AXL Targeting in Metastatic, Refractory, Adenoid Cystic Carcinoma: A Case Report. JCO Precis Oncol. 2024 Apr; 8:e2300633.
    View in: PubMed
    Score: 0.168
  20. Prognostic value of tumor volume doubling time in lung-metastatic adenoid cystic carcinoma. Oral Oncol. 2024 Apr; 151:106759.
    View in: PubMed
    Score: 0.167
  21. Outcomes in patients with adenoid cystic carcinoma of the lacrimal gland. Ophthalmic Plast Reconstr Surg. 2004 Jan; 20(1):22-6.
    View in: PubMed
    Score: 0.165
  22. Analysis of B7-H4 Expression Across Salivary Gland Carcinomas Reveals Adenoid Cystic Carcinoma-Specific Prognostic Relevance. Mod Pathol. 2024 Jan; 37(1):100371.
    View in: PubMed
    Score: 0.163
  23. Spatial Immunoprofiling of Adenoid Cystic Carcinoma Reveals B7-H4 Is a Therapeutic Target for Aggressive Tumors. Clin Cancer Res. 2023 08 15; 29(16):3162-3171.
    View in: PubMed
    Score: 0.161
  24. Comprehensive molecular characterization of adenoid cystic carcinoma reveals tumor suppressors as novel drivers and prognostic biomarkers. J Pathol. 2023 11; 261(3):256-268.
    View in: PubMed
    Score: 0.161
  25. Molecular analysis of chromosome 16q regions in dermal analogue tumors of salivary glands: a genetic link to dermal cylindroma? Am J Surg Pathol. 2002 Jun; 26(6):778-83.
    View in: PubMed
    Score: 0.148
  26. Differential expression of galectin-1 and galectin-3 in benign and malignant salivary gland neoplasms. Int J Oncol. 2000 Aug; 17(2):271-6.
    View in: PubMed
    Score: 0.130
  27. Prognostic factors for local recurrence and survival and impact of local treatments on survival in lacrimal gland carcinoma. Br J Ophthalmol. 2021 06; 105(6):768-774.
    View in: PubMed
    Score: 0.130
  28. Limited nonrandom chromosomal aberrations in a recurrent adenoid cystic carcinoma of the parotid gland. Cancer Genet Cytogenet. 1999 Feb; 109(1):66-9.
    View in: PubMed
    Score: 0.117
  29. Autoimmune Granulomatous Inflammation of Lacrimal Glands and Axonal Neuritis Following Treatment With Ipilimumab and Radiation Therapy. J Immunother. 2018 09; 41(7):336-339.
    View in: PubMed
    Score: 0.114
  30. Activating NOTCH1 Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potential Responsiveness to Notch1 Inhibitors. J Clin Oncol. 2017 Jan 20; 35(3):352-360.
    View in: PubMed
    Score: 0.101
  31. Immune Profiling of Adenoid Cystic Carcinoma: PD-L2 Expression and Associations with Tumor-Infiltrating Lymphocytes. Cancer Immunol Res. 2016 08; 4(8):679-87.
    View in: PubMed
    Score: 0.098
  32. An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma. Nat Genet. 2016 Mar; 48(3):265-72.
    View in: PubMed
    Score: 0.095
  33. Phase II study of gefitinib in patients with advanced salivary gland cancers. Head Neck. 2015 May; 37(5):644-9.
    View in: PubMed
    Score: 0.090
  34. A unifying gene signature for adenoid cystic cancer identifies parallel MYB-dependent and MYB-independent therapeutic targets. Oncotarget. 2014 Dec 30; 5(24):12528-42.
    View in: PubMed
    Score: 0.088
  35. Whole exome sequencing of adenoid cystic carcinoma. J Clin Invest. 2013 Jul; 123(7):2965-8.
    View in: PubMed
    Score: 0.079
  36. Detailed genome-wide SNP analysis of major salivary carcinomas localizes subtype-specific chromosome sites and oncogenes of potential clinical significance. Am J Pathol. 2013 Jun; 182(6):2048-57.
    View in: PubMed
    Score: 0.078
  37. TrkC signaling is activated in adenoid cystic carcinoma and requires NT-3 to stimulate invasive behavior. Oncogene. 2013 Aug 08; 32(32):3698-710.
    View in: PubMed
    Score: 0.076
  38. A comparison of the demographics, clinical features, and survival of patients with adenoid cystic carcinoma of major and minor salivary glands versus less common sites within the Surveillance, Epidemiology, and End Results registry. Cancer. 2012 Aug 15; 118(16):3945-53.
    View in: PubMed
    Score: 0.072
  39. Prognosis and risk factors for early-stage adenoid cystic carcinoma of the major salivary glands. Cancer. 2012 Jun 01; 118(11):2872-8.
    View in: PubMed
    Score: 0.071
  40. Histopathologic grading of salivary gland neoplasms: III. Adenoid cystic carcinomas. Ann Otol Rhinol Laryngol. 1990 Dec; 99(12):1007-9.
    View in: PubMed
    Score: 0.067
  41. C-kit gene mutations in adenoid cystic carcinoma are rare. Mod Pathol. 2010 Jun; 23(6):905-6; author reply 906-7.
    View in: PubMed
    Score: 0.064
  42. Mitochondrial mutations in adenoid cystic carcinoma of the salivary glands. PLoS One. 2009 Dec 30; 4(12):e8493.
    View in: PubMed
    Score: 0.063
  43. An orthotopic murine model of sinonasal malignancy. Clin Cancer Res. 2008 Nov 15; 14(22):7348-57.
    View in: PubMed
    Score: 0.058
  44. Vandetanib inhibits growth of adenoid cystic carcinoma in an orthotopic nude mouse model. Clin Cancer Res. 2008 Aug 15; 14(16):5081-9.
    View in: PubMed
    Score: 0.057
  45. Sinonasal adenoid cystic carcinoma: the M. D. Anderson Cancer Center experience. Cancer. 2007 Dec 15; 110(12):2726-31.
    View in: PubMed
    Score: 0.054
  46. Implications of methylation patterns of cancer genes in salivary gland tumors. Clin Cancer Res. 2006 Dec 15; 12(24):7353-8.
    View in: PubMed
    Score: 0.051
  47. Concomitant inhibition of epidermal growth factor and vascular endothelial growth factor receptor tyrosine kinases reduces growth and metastasis of human salivary adenoid cystic carcinoma in an orthotopic nude mouse model. Mol Cancer Ther. 2006 Nov; 5(11):2696-705.
    View in: PubMed
    Score: 0.050
  48. Promoter methylation of p16INK4a, RASSF1A, and DAPK is frequent in salivary adenoid cystic carcinoma. Cancer. 2005 Aug 15; 104(4):771-6.
    View in: PubMed
    Score: 0.046
  49. Large scale molecular analysis identifies genes with altered expression in salivary adenoid cystic carcinoma. Am J Pathol. 2002 Oct; 161(4):1315-23.
    View in: PubMed
    Score: 0.038
  50. Myoepithelium in salivary and mammary neoplasms is host-friendly. Adv Anat Pathol. 1999 Jul; 6(4):218-26.
    View in: PubMed
    Score: 0.030
  51. Adenoid cystic carcinoma of the head and neck: predictors of morbidity and mortality. Arch Otolaryngol Head Neck Surg. 1999 Feb; 125(2):149-52.
    View in: PubMed
    Score: 0.029
  52. Salivary neoplasms of the palate: a flow cytometric and clinicopathological analysis. J Laryngol Otol. 1993 Sep; 107(9):858-61.
    View in: PubMed
    Score: 0.020
  53. Basaloid squamous carcinoma of the head and neck. Immunohistochemical comparison with adenoid cystic carcinoma and squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 1993 Aug; 119(8):887-90.
    View in: PubMed
    Score: 0.020
  54. Biology and management of salivary gland cancers. Semin Radiat Oncol. 2012 Jul; 22(3):245-53.
    View in: PubMed
    Score: 0.019
  55. Flow cytometric DNA content of adenoid cystic carcinoma of submandibular gland. Correlation of histologic features and prognosis. Arch Otolaryngol Head Neck Surg. 1990 Nov; 116(11):1291-6.
    View in: PubMed
    Score: 0.017
  56. Minor salivary gland tumors of the lip and buccal mucosa. Laryngoscope. 1989 Jan; 99(1):6-9.
    View in: PubMed
    Score: 0.015
  57. Effect of initial treatment on disease outcome for patients with submandibular gland carcinoma. Arch Otolaryngol Head Neck Surg. 2007 Jun; 133(6):546-50.
    View in: PubMed
    Score: 0.013
  58. Histologically similar, synchronous or metachronous, lacrimal salivary-type and parotid gland tumors: A series of 11 cases. Head Neck. 1999 Sep; 21(6):512-6.
    View in: PubMed
    Score: 0.008
  59. c-erbB-2/neu oncogene and Ki-67 analysis in the assessment of palatal salivary gland neoplasms. Otolaryngol Head Neck Surg. 1995 Mar; 112(3):391-8.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.